CK Life Sciences International, the biotech unit controlled by the Li Ka-shing family, is expected to post a loss for last year due to an increase in R&D spending and a decline in the value of its ...

Dogwood Therapeutics, Inc. has announced that its largest shareholder, CK Life Sciences Int’l. (via its subsidiary Conjoint Inc.), is converting an outstanding $19.5 million loan into preferred ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A fresh report on the U.S. life sciences sector is back from the lab with an inconclusive prognosis despite an improved investment environment in 2024. The niche industry struggled throughout 2024 in ...

CK Life Sciences Int’l., (Holdings), Inc. (“CKLS”) has agreed, through its wholly-owned subsidiary, Conjoint Inc. (“Conjoint”), to assign to the Company all outstanding indebtedness under the ...

HONG KONG/LONDON, March 28 (Reuters) - Hong Kong conglomerate CK Hutchison Holdings Ltd (0001.HK), opens new tab has started preparations to spin off its global telecommunication assets and list ...

Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing ...

Largest shareholder, CK Life Sciences Int’l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood’s balance sheet ATLANTA, March 12, 2025 (GLOBE ...

Negotiation for the overall deal that covers a total of 43 ports in 23 countries is on an exclusive basis between CK Hutchison and the consortium for 145 days. Local media including Singtao Daily ...

These enzymes, called creatine kinases (CK), allow cells to transport energy produced at the mitochondria to where it is needed throughout the cell. Cancer cells rely on this machinery for ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Wave Life Sciences’ experimental ...